A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2006
10/25/2006	EP1714980A1 Human receptor proteins, related reagents and methods
10/25/2006	EP1714970A1 Use of inhibitors of RNAse A-family enzymes for stabilizing oligonucleotides having RNA interfering activity
10/25/2006	EP1714969A2 Immunostimulatory nucleic acid molecules
10/25/2006	EP1714966A1 Naphthylidine derivative having hiv integrase inhibitory activity
10/25/2006	EP1714652A2 Use of thiazolidinediones to prevent or delay onset of niddm
10/25/2006	EP1714650A1 Arginine-containing compositions for increasing blood flow
10/25/2006	EP1714648A1 Combination drug
10/25/2006	EP1713497A1 Use of factor viia for treating late complications of trauma
10/25/2006	EP1713496A1 Use of factor viia for treating trauma
10/25/2006	EP1524971B1 Improved transdermal delivery system
10/25/2006	EP1517909B1 Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
10/25/2006	EP1509498B1 Pentafluorosulfanyl-benzoylguanidine, method for the production thereof and its utilization as medicament or diagnostic agent and medicament containing same
10/25/2006	EP1490030B1 Nanoparticulate compositions of angiogenesis inhibitors
10/25/2006	EP1458718B1 Quinolinones as prostaglandin receptor ligands
10/25/2006	EP1401824B1 Aromatic hydroxamic acid derivatives useful as hdac inhibitors
10/25/2006	EP1401416B1 Use of c-kit inhibitors for treating inflammatory bowel diseases (ibd)
10/25/2006	EP1392689B1 Tri- and tetraaza-acenaphthylen derivatives as crf receptor antagonists
10/25/2006	EP1383511B1 Calcilytic compounds
10/25/2006	EP1370543B1 Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors
10/25/2006	EP1326617B9 Use of 11beta-(4-acetylphenyl)-17beta-hydroxy-17alpha-(1,1,2,2-pentafluoroethyl)estra-4,9-dien-3-one for the preparation of a medicament for the treatment fo breast, ovarian, endometrial cancer, myeloma and meningioma
10/25/2006	EP1278522B1 Pde-v inhibitors for treatment of parkinson's disease
10/25/2006	EP1265849B1 Compounds and methods to treat alzheimer's disease
10/25/2006	EP1265606B1 Cell adhesion inhibitors
10/25/2006	EP1219632B1 Steroids, their preparation, pharmaceutical compositions thereof and uses of the compounds
10/25/2006	EP1187613B9 Amide substituted imidazoquinolines
10/25/2006	EP1109901B1 GABA B RECEPTOR SUBTYPES GABA B-R1c AND GABA B-R2 AND HETERODIMERS THEREOF
10/25/2006	EP1097167B1 Neurotrophic growth factor
10/25/2006	EP1089998B1 Epothilone derivatives and their synthesis and use
10/25/2006	EP0912086B1 Method of screening for drugs for the treatment of alzheimer's disease
10/25/2006	EP0828849B1 High-affinity oligonucleotide ligands to pdgf
10/25/2006	CN1852904A Endurance improving agent
10/25/2006	CN1852893A (2S,4S)-4-fluoro-1-[4-fluoro-beta-(4-fluorophenyl)-L-phenylalanyl]-2-pyrrolidinecarbonitrile p-toluenesulfonic acid salt and anhydrous crystalline forms thereof
10/25/2006	CN1852731A Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
10/25/2006	CN1852730A Modulators of P-selectin glycoprotein ligand 1
10/25/2006	CN1852723A Use of pelargonium plant extracts
10/25/2006	CN1852709A Macrophage activation inhibitor
10/25/2006	CN1852708A Human beta-defensin secretion promoter
10/25/2006	CN1850279A PcrDNA vaccine, and its preparing method and use
10/25/2006	CN1850269A Function of GPR39 gene for central nervous system of mammal and its use
10/25/2006	CN1850246A Method for preparing Feier dropping pills
10/25/2006	CN1850174A Method for preparing Rhizoma cimicifugae formula granules
10/25/2006	CN1850163A Chinese medicne for eliminating sub-heath condition
10/25/2006	CN1850142A Method for preparing honeysuckle formula granules
10/25/2006	CN1850140A Method for preparing chrysanthemum formula granules
10/25/2006	CN1850067A Invivo oxyger-supply solution for injection, and its preparing method and use
10/25/2006	CN1850065A Use of oral conjugated linoleic acid and its derivative for increasing muscule and skin beauty
10/25/2006	CN1281624C Thrombin derivatives and its process for production
10/25/2006	CN1281606C Nitrogen-containing heterocyclic compound
10/25/2006	CN1281605C Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands
10/25/2006	CN1281604C Substituted pyrazole compounds
10/25/2006	CN1281603C Aminopyrrole compounds as antiinflammatory agents
10/25/2006	CN1281601C Bipyridyl derivatives as a highly selective cyclooxygenase-2 inhibitor
10/25/2006	CN1281598C Compounds and methods for modulation of estrogen receptors
10/25/2006	CN1281597C New compounds, which are potent inhibitors of Na<+>/Ca<2+> exchange mechanism and are useful in the treatment of arrhythmias
10/25/2006	CN1281588C Novel intermediate for preparation of pyrazolopyrimidinones
10/25/2006	CN1281585C Cyclic diamine compounds having fused-ring groups
10/25/2006	CN1281274C 6-fluorobicyclo [3.1.0] hexane derivatives
10/25/2006	CN1281270C Polypeptide, the conjugate thereof with doxorubicin and a pharmaceutical composition based thereon
10/25/2006	CN1281258C Cosmetic use of hop and ornithine
10/24/2006	US7126027 N-[(1-dimethylaminocycloalkyl)methyl]benzamide derivatives
10/24/2006	US7126015 Converting 2,3-O-isoproylideneglyceralde-hyde compound to a nitromethane derivative; transforming nitromethane derivative into a tetrahydrofuran derivative; intramolecular cyclisation to produce hexahydro-furo[2,3-b]furan-3-ol compound
10/24/2006	US7126012 Has affinity for melatonin receptors and/or selectivity for melatoninergic receptors; antiinflammatory and anticarcinogic agents
10/24/2006	US7126010 Benzylcycloalkyl amines as modulators of chemokine receptor activity
10/24/2006	US7126008 Carvedilol
10/24/2006	US7126001 Antiproliferative agents; antitumor agents
10/24/2006	US7125979 Upstream control elements of the proopiomelanocortin gene and their use
10/24/2006	US7125905 Pyrrole substituted 2-indolinone protein kinase inhibitors
10/24/2006	US7125904 Cardiovascular disorders; hypotensive agents; congestive heart failure
10/24/2006	US7125900 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
10/24/2006	US7125899 Microtubule-stabilizing agents useful in the treatment of a variety of cancers
10/24/2006	US7125898 Kinase inhibitors to mediate disease and as antiinflammatory agents
10/24/2006	US7125896 Thiophene carboxamide compounds as inhibitors of enzyme IKK-2
10/24/2006	US7125895 Arylalkylamine compounds as chemokine receptor antagonists for therapy and prevention of diseases such as arthritis or rheumatic diseases
10/24/2006	US7125892 Aryl aniline β2 adrenergic receptor agonists
10/24/2006	US7125891 Such as (1-((2,3-dihydro-2-(4-propyl-1H-imidazol-2-yl)-1H-indol-1 -yl)carbonyl)propyl)-carbamate; for inactivation of cholecystokinins
10/24/2006	US7125890 Immunology for viral diseases and biosynthesis of cytokines of anticancer drugs for tumors
10/24/2006	US7125889 Administering mixtures of heterocyclic imines and anticoagulants such as heparin or aspirin, to reduce blood coagualtion in mammals
10/24/2006	US7125887 Pyrrolidine modulators of CCR5 chemokine receptor activity
10/24/2006	US7125884 N-but-3-enyl norbuprenorphine and its use as analgesic
10/24/2006	US7125881 Use of pyrimidine—or triazine—2 carbonitiles for treating diseases associated with cysteine prostease activity and novel pyrimidine-2-carbonitile derivatives
10/24/2006	US7125878 For therapy and prophylaxis of cardiovascular diseases, diabetes, diabetes- associated disorders, inflammatory diseases, immunological disorders, dermatological disorders, oncological disorders and central nervous system disorders
10/24/2006	US7125877 Brain disorders; psychological disorders; central nervous system disorders; antidiabetic agents; hypotensive agents
10/24/2006	US7125873 Beta-amino tetrahydroimidazo (1, 2-a) pyrazines and tetrahydrotrioazolo (4, 3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/24/2006	US7125863 Inhibitors of dipeptidyl peptidase IV
10/24/2006	US7125862 Porphyrin-metal complexes and oxygen infusions containing the same
10/24/2006	US7125860 Cross-linked derivatives of hyaluronic acid
10/24/2006	US7125858 Hyaluronic acid in the treatment of cancer
10/24/2006	US7125855 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
10/24/2006	US7125715 Nucleic acid encoding a polypeptide promoting type II collagen formation and aggrecan production
10/24/2006	US7125714 Progenitor cell materials and methods
10/24/2006	US7125684 Treating fertility disorders; maternal-antigen-that-embryos-require (MATER)
10/24/2006	US7125564 Glycyrrhizin complex
10/24/2006	US7125547 Poly(diallylamine)-based bile acid sequestrants
10/24/2006	CA2332915C Compositions comprising gaba analogs and caffeine
10/24/2006	CA2274183C Benzodioxole, benzofuran, dihydrobenzofuran, and benzodioxane melatonergic agents
10/24/2006	CA2249402C Benzopyran derivatives having leukotriene-antagonistic action
10/24/2006	CA2237650C Benzamidoxime prodrugs as antipneumocystic agents
10/24/2006	CA2208199C Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitors
10/24/2006	CA2205315C Fluorinated vitamin d3 analogs
10/24/2006	CA2195663C Dihydrobenzofuranes

1 ... 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 ... 1564